In terms of how much impact the price reduction will make on its earnings ... step to limit cost-sharing for its insulin, and we encourage other insulin manufacturers to do the same.” ...

New-generation weight-loss drugs can retail for about $1,350 a month, but a new study from Yale University suggests they cost just $22 to make. Similarly, life-saving insulin can be manufactured ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often encounter barriers in obtaining insulin.